APA (7th ed.) Citation

El Mahdaoui, S., Hansen, M. M., von Essen, M. R., Hvalkof, V. H., Holm Hansen, R., Mahler, M. R., . . . Romme Christensen, J. (2024). CD11c+ B cells in relapsing–remitting multiple sclerosis and effects of anti‐CD20 therapy. Annals of Clinical & Translational Neurology, 11(4), 926. https://doi.org/10.1002/acn3.52009

Chicago Style (17th ed.) Citation

El Mahdaoui, Sahla, Marie Mathilde Hansen, Marina Rode von Essen, Victoria Hyslop Hvalkof, Rikke Holm Hansen, Mie Reith Mahler, Poul Jennum, Finn Sellebjerg, and Jeppe Romme Christensen. "CD11c+ B Cells in Relapsing–remitting Multiple Sclerosis and Effects of Anti‐CD20 Therapy." Annals of Clinical & Translational Neurology 11, no. 4 (2024): 926. https://doi.org/10.1002/acn3.52009.

MLA (9th ed.) Citation

El Mahdaoui, Sahla, et al. "CD11c+ B Cells in Relapsing–remitting Multiple Sclerosis and Effects of Anti‐CD20 Therapy." Annals of Clinical & Translational Neurology, vol. 11, no. 4, 2024, p. 926, https://doi.org/10.1002/acn3.52009.